A. Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice. Physiol Genomics 44: 843-852, 2012. First published July 17, 2012 doi:10.1152/physiolgenomics.00025.2012.-Epidemiological studies show that high HDL-cholesterol (HDLc) decreases the risk of cardiovascular disease. To map genes controlling lipid metabolism, particularly HDLc levels, we screened the plasma lipids of 36 AcB/BcA RC mouse strains subjected to either a normal or a high-fat/cholesterol diet. Strains BcA68 and AcB65 showed deviant HDLc plasma levels compared with the parental A/J and C57BL/6J strains; they were thus selected to generate informative F2 crosses. Linkage analyses in the AcB65 strain identified a locus on chromosome 4 (Hdlq78) responsible for high post-high fat diet HDLc levels. This locus has been previously associated at genome-wide significance to two regions in the human genome. A second linkage analysis in strain BcA68 identified linkage in the vicinity of a gene cluster known to control HDLc levels. Sequence analysis of these candidates identified a de novo, loss-of-function mutation in the ApoA1 gene of BcA68 that prematurely truncates the ApoA1 protein. The possibility of dissecting the specific effects of this new ApoA1 deficiency in the context of isogenic controls makes the BcA68 mouse a valuable new tool. mouse model; lipid profiles; genome-wide linkage analysis; de novo mutation in ApoA1 SEVERAL EPIDEMIOLOGICAL STUDIES have shown that the concentration of HDL cholesterol (HDLc) is inversely correlated with the risk of cardiovascular disease (CVD) (8). A number of mechanisms have been proposed to explain how HDL particles may mediate protection against atherosclerosis (reviewed in Ref. 1). These include the stimulation of reverse cholesterol transport, inhibition of LDL oxidation, inhibition of inflammation by suppressing expression of adhesion molecules and macrophage chemotactic proteins, reduction of lipoprotein retention, and attenuation of endothelial dysfunction.
SEVERAL EPIDEMIOLOGICAL STUDIES have shown that the concentration of HDL cholesterol (HDLc) is inversely correlated with the risk of cardiovascular disease (CVD) (8) . A number of mechanisms have been proposed to explain how HDL particles may mediate protection against atherosclerosis (reviewed in Ref. 1) . These include the stimulation of reverse cholesterol transport, inhibition of LDL oxidation, inhibition of inflammation by suppressing expression of adhesion molecules and macrophage chemotactic proteins, reduction of lipoprotein retention, and attenuation of endothelial dysfunction.
Twin and family studies have established that the level of plasma HDL is in part controlled by genetic factors (9) . Over the past decade, the study of HDL metabolic pathways and the identification of naturally occurring rare mutations have established a list of more than 19 loci and 50 candidate genes possibly involved in HDL modulation (reviewed in Refs. 13, 24) . These candidate genes encode several different types of proteins: structural apolipoproteins; cellular receptors, adaptors, and transporters; transcription factors; as well as plasmaand cell-associated enzymes and transfer proteins. Rare variants of the ABCA1 transporter gene have been associated with decreased HDLc (4); genome-wide association studies have revealed that common variants associated with blood lipids are also associated with CVD (35, 40) . Mouse models generate novel targets for the control of lipid metabolism; they also confirm existing associations, as an overwhelming majority of these are conserved between mice and humans (17) . Inbred strains of mice diverge widely in their response to high-fat, high-cholesterol diets, as measured by plasma lipid levels and susceptibility to fatty streak lesions and gallstone formation (32) . The phenotypic variation observed between inbred strains in response to high-fat diets has provided the basis for quantitative trait locus (QTL) studies that aim to identify genes controlling atherosclerosis and blood lipid levels (38, 42, 43) . For HDLc in particular, over 20 crosses involving at least 20 inbred strains have been used to map about 40 unique putative HDLc QTLs scattered on every somatic chromosome (43) . The genetic control of HDLc is therefore acknowledged to be extremely complex.
The AcB/BcA set of recombinant congenic mouse strains (RCS) is a series of 36 inbred strains produced from the second backcross generation of the two progenitor strains A/J and C57BL/6J (7) . Each individual RCS carries a small amount (ϳ12.5%) of DNA from one "donor" parental strain fixed as a set of discrete congenic segments on the background (87.5%) of the other parent. The AcB/BcA set has been genetically characterized with a panel of 625 simple sequence length polymorphism (SSLP) markers, and the position of all congenic fragments has been established (7) . The AcB/BcA recombinant congenic strains have proven to be highly useful in studying the genetic basis of the differential disease susceptibility reported between the A/J and C57BL/6J strains. This is exemplified by their recent use in studying a series of multigenic phenotypes, such as susceptibility to malaria and Salmonella infections, prepulse inhibition of acoustic startle, lung fibrosis, and several others (6, 7, 12, 18, 25, 26, 34) . Individual gene effects contributing to a complex trait can segregate in a single RCS and can thus be studied in isolation. In some cases, the relatively small size of the congenic segments fixed in individual RCS facilitates the search and testing of candidate genes (25) . In addition, secondary genetic effects can be detected in strains fixed for certain alleles at major mapped loci yet show deviations from expected phenotypes (6) . Finally, reassortment of parental haplotypes or appearance of novel mutations during the breeding of individual strains may generate "hyperphenotypes" that segregate as simple traits and that can quickly be cloned (26) .
To map genes involved in lipid metabolism in general and HDL formation in particular, we undertook a systematic screening of plasma lipid levels in the 36 AcB/BcA RC strains before and after 4 wk of a proatherogenic high-fat, highcholesterol diet. From this initial screen, we focused on two strains showing phenotypes that deviated substantially from the parental A/J and C57BL/6J strains. Linkage analyses in secondary crosses, fine mapping, and sequence analyses identified the phenotype-causing genetic defect in one instance and has revealed novel and previously associated candidate genes in the second instance.
MATERIALS AND METHODS
Animals. Inbred C57BL/6J (B6), AKR, and A/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). The set of 36 AcB/BcA RCS, derived from A/J and B6 parents, were generated according to a previously described breeding scheme and genotyping protocol (7) . (AcB65 ϫ AKR) and (BcA68 ϫ AKR) F1 crosses were generated; F2 crosses were then performed by standard (F1-brother ϫ F1-sister) mating. All mice were handled according to the guidelines and regulations of the Canadian Council on Animal Care. All protocols were approved by the Montreal General Hospital Research Institute Animal Care Committee.
Diet and lipid measurements. For each RC strain, three to seven mice (5.5 on average) per sex, between 8 and 12 wk of age, were fed a proatherogenic, high-fat, high-cholesterol diet (ID 90221; Teklad Research Diets, Madison, WI) for 4 consecutive weeks. The diet contained (by weight) 75% Purina Mouse Chow, 7.5% cocoa butter, 1.25% cholesterol, and 0.5% sodium cholate. Mice were weighed weekly. Blood collection was performed both pre-and postdiet following 4 -6 hours of fasting. For prediet collection, blood was drawn from the lateral saphenous vein; cardiac puncture under anesthesia was performed for exsanguination at the end of the diet period. Plasma lipid related variables, including HDLc and total cholesterol (TC), were measured by enzymatic assays employing colorimetric end points (3, 10) . Each assay was performed in triplicate. The UCLA Lipid/Lipoprotein Laboratory, which performed the lipid analyses, participates in the Centers for Disease Control and Prevention National Heart, Lung, and Blood Institute Lipid Standardization Program (laboratory ID# LSP-251); it also undergoes quarterly certification by the Centers for Disease Control.
Genotyping. Tail biopsies were obtained from all animals, and genomic DNA was isolated by a standard procedure involving proteinase K treatment. Primer pairs defining dinucleotide repeat markers informative for the A/J, C57BL/6J, and AKR mouse strains were purchased from Research Genetics (Huntsville, AL) and Biocorp (Montreal, QC, Canada). A complete list of microsatellite markers used for genotyping is included in Table 1 .
Statistical and bioinformatics analyses. Statistical analyses were conducted with the freely available program R; linkage was performed with the package "R/qtl," version 1.23-16. The scanone function of the R/qtl library was used to perform maximum likelihood interval mapping (EM) of the phenotype on genetic markers using sex as an additive covariate term. Significance values were evaluated with 10,000 permutations. The logarithm of the odds (LOD) support interval of QTL peaks was calculated using a 1.5 LOD drop by R/qtl on the interval map. Sequence polymorphisms were identified in the candidate genes using the Sanger1 high density single nucleotide polymorphism (SNP) set (65.2ϩ million) from the mouse phenome database (http://phenome.jax.org/SNP) (14) . P values shown in the figures are a result of two-tailed t-tests with *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001.
ApoA1 sequencing. Regional transcript maps of chromosome 9 were obtained from the UCSC Genome Browser (http://genome. ucsc.edu). Exons from the ApoA1 gene were amplified from genomic DNA of the parental C57BL/6J strain, as well as from BcA68. The following oligonucleotides were used for PCR amplification of 3 fragments containing the four exons of ApoA1: exon 1, 5=-TTGTTC-CAGGCTCAGAGGGCACTA-3= and 5=-ATCAACTGGGAGGCGCT-ATGGAG-3=; exons 2-3, 5=-ATATCTCGCACCTTTAGCCATTCT-3= and 5=-CTCAGTTCCAGCATCTTCTCA-3=; exon 4, 5=-TTCGGGG-AAACTAGGACCATAGCA-3= and 5=-AGTGCGGCACCATGTTCT-CACG -3=. The PCR products were visualized by agarose gel electrophoresis to confirm size. Cycle sequencing of individual ApoA1 exons was performed on both DNA strands at the McGill University/Genome Quebec Innovation Centre (Montreal, QC, Canada). Reactions were done in the presence of fluorescently labeled BigDye Terminator (Applied Biosystems, Foster City, CA); the products were analyzed using an automated ABI 3700 instrument (Applied Biosystems). Genotyping of the QW22-23CStop mutation was done in 104 (BcA68 ϫ AKR)F2 mice by digesting the exon 2-3 fragment amplified with PCR using the MwoI restriction enzyme according to manufacturer's directions. Digested fragments were visualized by electrophoresis through 3% agarose gels.
Western blot analysis. Mice sera were separated in 4 -12% Novex NuPAGE Bis-Tris gradient gels (Invitrogen) under reducing conditions. Separated proteins were transferred to nitrocellulose membranes. Nonspecific sites were blocked with 5% skim milk in Trisbuffered saline for 1 h at room temperature. Membranes were incubated overnight with rabbit anti-Apo A1 polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:500 dilution, followed by incubation with horseradish peroxidase-conjugated anti-rabbit IgG at a 1:200,000 dilution (Amersham Biosciences, Piscataway, NJ). The membranes were incubated in SuperSignal West Pico detection solution (Pierce, Rockford, IL) and exposed to X-ray film. The loading control gel was stained with Biosafe Coomassie stain (Bio-Rad).
RESULTS
Screening of the AcB/BcA RCS. To identify genes involved in lipid metabolism in mice, 36 AcB/BcA RCS, along with parental controls (A/J and C57BL6/J), were fed a proatherogenic, high-fat diet (7.5% cocoa butter diet, 1.25% cholesterol, 0.5% cholate) for a period of 4 wk. Lipid-related fractions, including HDLc and TC, were measured before and after the diet period; the strain distribution patterns were then analyzed. Figure 1 presents the amounts (mg/dl) of HDLc in the plasma of the AcB/BcA RCS, along with that of the A/J and C57BL/6J (B6) parental strains, according to diet: normal diet (Fig. 1A) and following 4 wk of a proatherogenic, high-fat diet (Fig. 1B) . Figure 1C presents the difference between the two conditions (normal vs. high-fat diet) in plasma taken from the same animal (Fig. 1C) . Total serum cholesterol (TC) was also Fig. 1 . High-density lipoprotein cholesterol (HDLc) levels in AcB/BcA recombinant congenic strains of mice. HDLc in AcB/BcA mice when fed a normal chow diet (A) or a high-fat diet (B). The difference in HDLc levels between the 2 diets per mouse (C). HDLc fractions were determined in 3-7 females and males prior to and following a 4 wk high-fat diet. Each point represents 1 mouse and is overlaid on a standard box and whisker plot.
measured in the plasma of these animals under the same conditions (Fig. 2) . When the B6 and A/J parental strains were fed a normal diet, HDL was the primary cholesterol transport particle found in their plasma, corresponding to ϳ85 and 90% of their TC, respectively. Conversely, following 4 wk of the high-fat diet, HDLc decreased to ϳ20% of the TC in both parental strains, paralleled with a 1.6-and 1.8-fold increase in TC, respectively (Figs. 1C and 2C) . A similar increase was observed in both sexes, although females had significantly lower levels of plasma cholesterol than males (P Ͻ 0.001). Strains of the AcB/BcA RC set presented a continuous phenotypic distribution of cholesterol levels (TC and HDLc) when fed either a normal or a high-fat diet, indicating the presence of multigenic determinants controlling plasma cholesterol. The diet-induced change in plasma cholesterol composition was similarly heterogeneous across RCS (Fig. 3) . Changes in HDLc and TC levels were significantly correlated, although weakly so (R 2 ϭ 0.12, P Ͻ 5e12). This suggests that HDLc and TC serum levels have some genetic controls in common, but that they also have some that are specific to each of them. Two notable outliers were identified, BcA68 and AcB65. BcA68 plasma contained extremely low levels of HDLc and TC, independent of diet (Figs. 1, 2). When fed a high-fat diet, BcA68 mice had plasma TC levels that rose by 68.0 mg/dl, an increase comparable to that of other RCS, increases that ranged between 49.2 and 158 mg/dl; this was not the case with HDLc levels. A second strain of interest, AcB65, also demonstrated a lack of change in HDLc levels following a high-fat diet (Fig. 3) . On a normal diet, the proportion of HDLc with respect to TC in this Total Cholesterol (mg/dL) strains, suggesting specific parental allele assortments or a spontaneously occurring mutation during the derivation of these strains.
Phenotype of outcrosses between strains of interest.
To further investigate the mode of inheritance of the extremely low HDLc phenotype seen in BcA68 and the high postdiet HDLc phenotype seen in AcB65, informative outcrosses with the AKR strain were generated (Fig. 4) . When fed a normal diet, mice of the (BcA68 ϫ AKR)F1 generation cross showed intermediate HDLc levels compared with those observed in the AKR and BcA68 parents, consistent with a codominant transmission of the trait. Segregation analyses showed that 26 of the 106 (BcA68 ϫ AKR)F2 (24.6%) displayed the extremely low HDLc phenotype, suggesting that a single autosomal mutation is responsible for this phenotype in BcA68 mice.
Similarly, an intermediate HDLc phenotype was observed in (AcB65 ϫ AKR)F1 mice compared with both parental strains. However, HDLc levels in the (AcB65 ϫ AKR)F2 mice were continuously distributed. Significant differences in HDLc levels were noted between (AcB65 ϫ AKR)F2 males and females, as shown in Fig. 4B (74 vs. 46 mg/dl, respectively) .
Mapping Hdlq78, a locus conferring high postdiet HDLc. To map the locus (loci) controlling the high HDLc phenotype in AcB65 mice post-high fat diet, we performed a genome scan using 106 SSLP markers on 186 (AcB65 ϫ AKR)F2 animals. Linkage analysis performed on HDLc and non-HDLc (TCHDLc) identified a single locus on chromosome 4 that controls HDLc levels (Fig. 5) . No significant linkage was found between TC (or non-HDLc) in the (AcB65 ϫ AKR)F2 cross. The peak of linkage occurred at the marker D4Mit178, with an LOD score of 5.97 and a P value of 0.0003; the 1.5 LOD interval of the locus spanned between D4Mit288 and D4Mit16, covering 71 Mb on chromosome 4. This locus, which we will refer to as Hdlq78, controls ϳ8% of the observed phenotypic variance. The effect size of Hdlq78 was 16.7 mg/dl in females [57.0 Ϯ 19.1 for KK (K for AKR alleles)] homozygotes vs. 40.3 Ϯ 11.2 for AA (A for A/J alleles) and 16.3 mg/dl in males (KK ϭ 83.2 Ϯ 18.8, AA ϭ 66.9 Ϯ 9.5 mg/dl). It has been hypothesized that when human genome-wide associations and mouse QTL analysis identify the same region for the same phenotype, it is because variation in the same orthologous segment is responsible (17) . Therefore, the Hdlq78 interval was compared with human association data as indicated in Fig.  5D (40, 43) . There appear to be two subpeaks within the Hdlq78 locus, suggesting the possibility that two loci underlie the effect. The trough separating the two subpeaks corresponds to where the two orthologous human regions on chromosomes 9p and 1p join. Both of these have been significantly associated with HDLc levels (Fig. 5, B and D) . The more proximal peak observed corresponds to an association with the TTC39B gene, located at 82.86 Mb in the mouse, and the distal peak corresponds to an association with a cluster of genes from MACF1-PABPC4, located at 123.3 Mb in the mouse.
Mapping low HDLc levels in BcA68 mice. The extreme and bimodal phenotypic distributions in (BcA68 ϫ AKR)F2 mice suggested the possibility of a de novo mutation unrelated to its congenic segments. As such, a relatively low-coverage genotyping panel of 21 markers was typed on 41 mice from both extremes of the F2 distribution. From this analysis, the low HDLc phenotype was linked to a locus on chromosome 9 with an LOD score of 24.25, as shown in Fig. 6A . After initial linkage, eight additional markers were added to chromosome 9, which refined the peak of linkage to a region centered on D9Mit130. This peak of linkage coincided with a cluster of genes known to be involved in lipid metabolism (ApoA1, (Fig. 6C) . The presence of these mutations predicts the synthesis of a truncated 22aa ApoA1 protein in the BcA68 RC strain in place of the wild-type 264aa protein; however, no ApoA1 protein was detected in this strain (Fig. 6D) . The 66 -67GCϾTT mutation in ApoA1 destroys an MwoI restriction site in the genomic DNA. Using this diagnostic restriction assay, we genotyped the remainder of the BcA68-derived (BcA68 ϫ AKR)F2 mice to correlate the presence of the ApoA1 mutant allele with the low HDLc phenotype. As shown in The 22-23WQϾCStop mutation is not found in the A/J and C57BL/6J parental strains nor in any other strains of the AcB/BcA RCS set. It is a de novo mutation that emerged on a C57BL/6J genomic segment and that became fixed during the breeding of BcA68. When fed a normal diet, BcA68 animals appear healthy; they do not show any gross abnormality and present normal longevity. These ApoA1 Ϫ/Ϫ mice may be useful as an in vivo model of ApoA1 deficiency.
DISCUSSION
HDLc metabolism is acknowledged to be highly complex. In human populations, Teslovich et al. (40) recently identified 95 loci associated with the control of lipid metabolism. Taken together, these loci accounted for 10 -12% of the observed phenotypic variance. This complexity is mirrored in mice, where Ͻ100 quantitative trait loci have been reported to control natural variation in HDLc levels (reviewed in Ref. 43 ). Mouse models are used to identify novel targets for the control of lipid metabolism, as well as to confirm existing associations, since an overwhelming majority of them are conserved between mice and humans (17) . In mice, the degree of experimental variation is minimized, such that each linkage peak explains 10 Ϯ 8% of phenotypic variation (43). The interrogation of the AcB/BcA RCS for plasma lipids on a normal and a high-fat, high-cholesterol diet allowed us to rapidly identify at least two strains (AcB65 and BcA68) that showed a highly deviant HDLc-related phenotype compared with both the A/J and C57BL/6J parental stains. Following a change in diet, these RCS responded less than other strains with respect to HDLc levels, but their TC response was normal. These hyperphenotypes may arise from unique reassortment of parental alleles or may be due to novel mutations arising during derivation of the strains, which become fixed during the inbreeding of one or more strains (22) .
Genetic analysis of the AcB65 strain, whose HDLc levels are high following a high-fat diet, revealed a novel, AKRderived locus on chromosome 4, Hdlq78. The Hdlq78 locus controlled 8% of observed phenotypic variance and increased mean post-high fat diet level of HDLc by 16.5 mg/dl on average. The 1.5 LOD interval of Hdlq78 spans between D4Mit288 and D4Mit16; however, a trough separates two possible subpeaks within the interval. These two peaks each contain interesting candidate genes known to be implicated in important pathways, as well as genes whose human orthologs have been strongly associated with the control of HDLc levels.
The proximal portion of Hdlq78 is highly associated with HDLc levels in humans, especially the Tetratricopeptide repeat domain 39B (TTC39B) gene. While the function and mechanism of action of Ttc39b are not entirely clear, there is an association between its expression levels and HDLc levels (40) . As a proof of concept, when Ttc39b is knocked down by shRNA in the mouse, significantly higher HDLc levels are observed (40) ; this makes Ttc39b a very strong candidate gene for HDLc regulation. Of the 336 known SNPs between A/J and AKR at this locus (14) , none are predicted to alter the amino acid sequence of the full-length gene product (transcript ENS-MUST00000102823, 617 amino acids). However, the Ttc39b gene has four additional putative protein coding transcripts (ENSMUST00000048274, ENSMUST00000030205, ENS-MUST00000148811, and ENSMUST00000150522), which respectively encode 518, 209, and two 179 amino acid long
proteins. An SNP located at position 82,905,359 of chromosome 4 (rs28317504) is predicted to result in the presence of a stop codon in the 209-and 179-amino acid long proteins, leading to a 39-amino acid truncation from the COOH terminus. The function of these transcripts should be studied further to determine which of them, if any, contribute to HDL regulation. Other potential candidates within the proximal portion of Hdlq78 include a family of 21 Major Urinary proteins (Mup1-21) with lipid binding ability (lipocalin domains), which are excreted into the urine.
The distal subpeak of Hdlq78 overlaps almost identically with the previously described Hdlcho locus (peak at 49 cM ϳ105 Mb) identified in a (B6 ϫ A/J)F2 cross (5) . In addition to its association with HDLc control in the mouse, this region has also been strongly associated with HDLc regulation in humans, particularly the MACF1, BMP8A, PPIEL, and PABPC4 genes (40) . In the AcB65 strain, a nonsynonymous coding change is present in the Macf1 gene (rs2755370), leading to a V1756A substitution; another nonsynonymous mutation is present in Pabpc4 (rs32502744), which leads to an A502T substitution. In both cases, AKR and B6 strains share a common genotype different from the A/J or AcB65 genotype. Other notable genes within the distal portion of Hdlq78 include the receptor for leptin satiety hormone (Lepr), a sterol transport protein (Scp2), and Pcsk9, which is involved in LDL receptor turnover (16) , as well as Angptl3. Indeed, Angptl3 deficiency has been reported to decrease HDLc levels via Lipg or Lpl (29, 36, 37) . In this intercross, HDLc levels were influenced in the same direction by both proximal and distal regions of Hdlq78. Linkage to two strongly associated human genes under these two regions raises interesting possibilities for furthering the study of human association data in a more controlled model. At this point, however, it is impossible to determine whether one or more distinct genes in the Hdlq78 locus are actually responsible for the observed HDLc phenotype. The presence of several strong candidates, including those from human association studies, suggests future work should begin with the generation of shows that mice with the KK genotype had normal levels of HDLc, while those with the BB (BcA68) genotype all had extremely reduced levels. C: proximity to the ApoAI/CIII/AIV/AV gene cluster prompted the sequencing of ApoA1, which revealed the presence of a 66 -67GCϾTT mutation. D: Western blot analysis shows that no ApoA1 protein is detectable in BcA68 mice (bottom). A Coomassie-stained sample of full serum is shown as a loading control (top), where the absence of a band at 28 kDa is also evident. E: the 66 -67GCϾTT mutation in ApoA1 (resulting in 22-23WQϾCStop) destroys an MwoI restriction site in the genomic DNA, which is used as a marker here. The effect of homozygosity or heterozygosity with respect to either wild-type (ϩ; ApoA166 -67GC) or mutated (Ϫ; ApoA166 -67TT) ApoA1 alleles on plasma HDLc levels is shown.
congenic and subcongenic mice to assess the contribution of individual genes.
A similar genetic analysis using the BcA68 RCS led to the identification of a nonsense mutation in the ApoA1 gene, which resulted in extremely low levels of HDLc as a single Mendelian-type effect. This genetic effect was unlinked to donor-derived congenic segments in the AcB/BcA RCS set but, rather, resulted from the presence of a de novo mutation in BcA68. Interestingly, this is the second de novo mutation controlling a phenotype of interest in the AcB/BcA RCS set (27) .
The GCϾTT substitution in exon 3 of the ApoA1 gene of BcA68 introduces a premature termination codon at a position corresponding to amino acid 23 in the normal 243-amino acid, mature ApoA1. Considering the position of the mutation, this 22 amino acid-truncated ApoA1 protein is predicted to be functionally inert and was undetectable, leading to HDLc deficiency in BcA68. To our knowledge, this is the first naturally occurring ApoA1 null mutation reported in mice. The fact that the 22-23WQϾCStop mutation is not present in any other strain of the AcB/BcA RC set suggests that it occurred relatively late in the generation of the BcA68 strain. In humans, homozygosity for several nonsense mutations in the ApoA1 gene have been reported (15, 21, 28, 30, 31, 33, 39, 45) , as well as compound heterozygosity where one of the mutations was a nonsense mutation (20, 23) . These mutations were all associated with extremely low levels or absence of HDLc. This is in agreement with our observation that the extremely low HDLc phenotype inherited from BcA68 segregates as a recessive single gene effect in two different F2 crosses (data only shown for BcA68 ϫ AKR), corresponding to a high penetrance of the mutation. At this point, the size and composition of HDL particles from BcA68 mice have not been investigated, though it seems they contain no residual ApoA1 protein.
Despite the clear link between ApoA1 and HDL deficiency, a clear relationship between ApoA1 and the development of atherosclerotic lesions remains to be demonstrated (19, 41) . According to previous calculations, ϳ91% of the genetic material of BcA68 mice is derived from the parental C57BL/6J inbred strain (7) . Since C57BL/6J are susceptible to dietinduced atherosclerosis (32) , it could be of interest to study the effect of a long-term atherogenic diet on the BcA68 strain, either on its natural genetic background or in crosses with sensitized strains (Apoe Ϫ/Ϫ , human CETP transgenic model, etc.). Similarly, in humans, clinical heterogeneity is observed in patients with APOA1 deficiency; several pathologies have been reported, including CVD (21, 30) , but also corneal opacity (15, 39) , xanthoma (15, 21, 30) , neuropathy (30, 31) , and hepatomegaly (15, 39) . Possible explanations for this pleiotropic effect of APOA1 deficiency may include the influence of environmental risk factors, such as age, diet, alcohol consumption, and smoking, but also of interactions with unknown additional genetic defects of various expressivities.
One important technical feature of the targeted ApoA1 KO animals is to be taken into consideration. The ApoA1 null mutation is introduced using targeted embryonic stem cells from a 129 background (44) . Within the ApoA1 tm1Unc mouse, even after extensive backcrossing efforts, this mutation therefore remains surrounded by 129-derived genetic material. Unfortunately, ApoA1 is part of a very tight cluster of genes involved in lipid metabolism: ApoA1, Apoc3, Apoa4, and Apoa5. Among the few genes with modulated expressions described in ApoA1 KO mice (2), there was Apoc3, which sits immediately distal to ApoA1 on mouse chromosome 9 (Ͻ3 kb apart) (11) . It remains to be seen whether Apoc3 expression is modulated by the ApoA1 null mutation or whether differences in expression are due to Apoc3 alleles of C57BL/6 and 129 origin or even if other genes within that 129 congenic segment indirectly affect its expression. Callow and colleagues (2) elegantly showed evidence supporting the latter two possibilities in their paper. Differential expression of the Apoc3 gene in the targeted ApoA1 KO mouse could thus be responsible for some of the other detected differences in gene expression. In the BcA68 strain, the null mutation occurred within a large C57BL/6J-derived genomic segment. Therefore, transfer of the ApoA1 null mutation from the BcA68 mouse into a pure C57BL/6 genetic background through backcrossing will constitute a much more accurate ApoA1 null model.
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